Cargando…
Expression of Monocarboxylate Transporter 1 in Immunosuppressive Macrophages Is Associated With the Poor Prognosis in Breast Cancer
Monocarboxylate transporter 1 (MCT1) participates in the transport of lactate to facilitate metabolic reprogramming during tumor progression. Tumor-associated macrophages (TAMs) are also involved in the inflammatory adaptation of the tumor microenvironment (TME). This study aimed to determine the co...
Autores principales: | Li, Bei, Yang, Qian, Li, Zhiyu, Xu, Zhiliang, Sun, Si, Wu, Qi, Sun, Shengrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596686/ https://www.ncbi.nlm.nih.gov/pubmed/33178603 http://dx.doi.org/10.3389/fonc.2020.574787 |
Ejemplares similares
-
Alterations in Immune-Related Genes as Potential Marker of Prognosis in Breast Cancer
por: Li, Bei, et al.
Publicado: (2020) -
Monocarboxylate Transporter 4 (MCT4) Overexpression Is Correlated with Poor Prognosis of Osteosarcoma
por: Liu, Yannan, et al.
Publicado: (2019) -
High expression of monocarboxylate transporter 4 predicts poor prognosis in patients with lung adenocarcinoma
por: Ruan, Yushu, et al.
Publicado: (2017) -
ALOX5AP Predicts Poor Prognosis by Enhancing M2 Macrophages Polarization and Immunosuppression in Serous Ovarian Cancer Microenvironment
por: Ye, Xiang, et al.
Publicado: (2021) -
NRBP2 Functions as a Tumor Suppressor and Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer
por: Li, Zhiyu, et al.
Publicado: (2021)